Effects of selenium pretreatment on cisplatin-induced chromosome aberrations in wistar rats.

Autor: Antunes LM; Departamento Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil. lugreggi@gly.fcfrp.usp.br, Francescato HD, Darin JD, de Lourdes P Bianchi M
Jazyk: angličtina
Zdroj: Teratogenesis, carcinogenesis, and mutagenesis [Teratog Carcinog Mutagen] 2000; Vol. 20 (6), pp. 341-8.
DOI: 10.1002/1520-6866(2000)20:6<341::aid-tcm3>3.0.co;2-4
Abstrakt: Selenium is an essential trace element and a potent anticancer agent. Extensive laboratory studies demonstrate that selenium is an effective chemopreventive agent in various sites in animals. The administration of selenium as a chemopreventive agent raises the question whether the antioxidant selenium, alone or in combination with other dietary antioxidants, could protect non-tumor cells from the clastogenic effect of cisplatin. Therefore, the present study was undertaken to investigate the modulatory effects of selenium, combined or not with vitamin C, on cisplatin-induced chromosomal aberrations in Wistar rat bone marrow cells. The animals were sacrificed 18, 24, or 72 h after cisplatin injection. The results obtained in Wistar rat bone marrow cells showed a slight nonsignificant reduction in the total number of chromosomal aberrations induced by cisplatin (5 mg/kg b.w.) observed in the animals that received a pretreatment with a single dose of selenium (2 mg/kg b.w.). The administration of two doses of selenium (1 mg/kg b.w.) also did not inhibit the chromosomal damage induced by cisplatin. In the present study, no protective response was obtained with either a single or double dose of selenium in rats treated with cisplatin. Furthermore, the combination between selenium+vitamin C was no more effective than vitamin C alone in the protection against damage caused by this antitumor drug. Further investigations, with other forms of selenium, are necessary to elucidate a possible protective role of selenium in clastogenicity induced by free radicals generated by antitumor drugs.
Databáze: MEDLINE
Externí odkaz: